Titre : Atrophie parodontale

Atrophie parodontale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Hyperplasia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Atrophie parodontale : Questions médicales les plus fréquentes", "headline": "Atrophie parodontale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Atrophie parodontale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Atrophie parodontale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies parodontales", "url": "https://questionsmedicales.fr/mesh/D010510", "about": { "@type": "MedicalCondition", "name": "Maladies parodontales", "code": { "@type": "MedicalCode", "code": "D010510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Résorption alvéolaire", "alternateName": "Alveolar Bone Loss", "url": "https://questionsmedicales.fr/mesh/D016301", "about": { "@type": "MedicalCondition", "name": "Résorption alvéolaire", "code": { "@type": "MedicalCode", "code": "D016301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.500" } } }, { "@type": "MedicalWebPage", "name": "Récession gingivale", "alternateName": "Gingival Recession", "url": "https://questionsmedicales.fr/mesh/D005889", "about": { "@type": "MedicalCondition", "name": "Récession gingivale", "code": { "@type": "MedicalCode", "code": "D005889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.625" } } }, { "@type": "MedicalWebPage", "name": "Perte d'attache parodontale", "alternateName": "Periodontal Attachment Loss", "url": "https://questionsmedicales.fr/mesh/D017622", "about": { "@type": "MedicalCondition", "name": "Perte d'attache parodontale", "code": { "@type": "MedicalCode", "code": "D017622", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Atrophie parodontale", "alternateName": "Periodontal Atrophy", "code": { "@type": "MedicalCode", "code": "D055093", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Frederik Barkhof", "url": "https://questionsmedicales.fr/author/Frederik%20Barkhof", "affiliation": { "@type": "Organization", "name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden." } }, { "@type": "Person", "name": "Maria Teresa Pellecchia", "url": "https://questionsmedicales.fr/author/Maria%20Teresa%20Pellecchia", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", Neuroscience Section, University of Salerno, Baronissi, SA, Italy." } }, { "@type": "Person", "name": "Iva Stankovic", "url": "https://questionsmedicales.fr/author/Iva%20Stankovic", "affiliation": { "@type": "Organization", "name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia." } }, { "@type": "Person", "name": "Gregor K Wenning", "url": "https://questionsmedicales.fr/author/Gregor%20K%20Wenning", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } }, { "@type": "Person", "name": "Klaus Seppi", "url": "https://questionsmedicales.fr/author/Klaus%20Seppi", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Nomogram predicting the efficacy of transurethral surgery in benign prostatic hyperplasia patients.", "datePublished": "2024-03-14", "url": "https://questionsmedicales.fr/article/38485798", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40520-024-02708-8" } }, { "@type": "ScholarlyArticle", "name": "Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review.", "datePublished": "2023-11-09", "url": "https://questionsmedicales.fr/article/38027158", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1287212" } }, { "@type": "ScholarlyArticle", "name": "STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.", "datePublished": "2023-10-20", "url": "https://questionsmedicales.fr/article/37866665", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cellsig.2023.110933" } }, { "@type": "ScholarlyArticle", "name": "The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia.", "datePublished": "2023-11-08", "url": "https://questionsmedicales.fr/article/38027182", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1290639" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia.", "datePublished": "2022-10-19", "url": "https://questionsmedicales.fr/article/36270339", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.urology.2022.09.026" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D009057" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la bouche", "item": "https://questionsmedicales.fr/mesh/D009059" }, { "@type": "ListItem", "position": 4, "name": "Maladies parodontales", "item": "https://questionsmedicales.fr/mesh/D010510" }, { "@type": "ListItem", "position": 5, "name": "Atrophie parodontale", "item": "https://questionsmedicales.fr/mesh/D055093" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Atrophie parodontale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Atrophie parodontale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Atrophie parodontale", "description": "Comment diagnostiquer l'atrophie parodontale ?\nQuels tests sont utilisés pour évaluer l'atrophie ?\nQuels signes cliniques indiquent l'atrophie ?\nL'atrophie parodontale est-elle réversible ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Atrophie parodontale", "description": "Quels sont les symptômes de l'atrophie parodontale ?\nL'atrophie parodontale cause-t-elle des douleurs ?\nPeut-on avoir des gencives qui saignent ?\nComment l'atrophie affecte-t-elle l'apparence des dents ?\nY a-t-il un lien entre l'atrophie et la sensibilité dentaire ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Atrophie parodontale", "description": "Comment prévenir l'atrophie parodontale ?\nQuel rôle joue le brossage des dents ?\nLes produits de rinçage buccal sont-ils utiles ?\nL'alimentation influence-t-elle la santé parodontale ?\nFumer affecte-t-il la santé parodontale ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Atrophie parodontale", "description": "Quels traitements sont disponibles pour l'atrophie parodontale ?\nLa chirurgie est-elle nécessaire pour traiter l'atrophie ?\nLes antibiotiques sont-ils utilisés dans le traitement ?\nComment la thérapie au laser aide-t-elle ?\nLes traitements sont-ils douloureux ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Atrophie parodontale", "description": "Quelles complications peuvent survenir avec l'atrophie ?\nL'atrophie parodontale peut-elle affecter la santé générale ?\nY a-t-il un risque accru de diabète ?\nComment l'atrophie affecte-t-elle la qualité de vie ?\nLes infections parodontales peuvent-elles se propager ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Atrophie parodontale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'atrophie ?\nLe stress a-t-il un impact sur la santé parodontale ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nUne alimentation déséquilibrée influence-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'atrophie parodontale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un examen clinique et des radiographies dentaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'atrophie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent l'atrophie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent la récession gingivale et la mobilité dentaire." } }, { "@type": "Question", "name": "L'atrophie parodontale est-elle réversible ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'atrophie parodontale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine." } }, { "@type": "Question", "name": "L'atrophie parodontale cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents." } }, { "@type": "Question", "name": "Peut-on avoir des gencives qui saignent ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire." } }, { "@type": "Question", "name": "Comment l'atrophie affecte-t-elle l'apparence des dents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale." } }, { "@type": "Question", "name": "Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids." } }, { "@type": "Question", "name": "Comment prévenir l'atrophie parodontale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles." } }, { "@type": "Question", "name": "Quel rôle joue le brossage des dents ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales." } }, { "@type": "Question", "name": "Les produits de rinçage buccal sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la santé parodontale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives." } }, { "@type": "Question", "name": "Fumer affecte-t-il la santé parodontale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'atrophie parodontale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour traiter l'atrophie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils utilisés dans le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales." } }, { "@type": "Question", "name": "Comment la thérapie au laser aide-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal." } }, { "@type": "Question", "name": "Les traitements sont-ils douloureux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'atrophie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte de dents, des infections et des problèmes de mastication." } }, { "@type": "Question", "name": "L'atrophie parodontale peut-elle affecter la santé générale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de diabète ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques." } }, { "@type": "Question", "name": "Comment l'atrophie affecte-t-elle la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi." } }, { "@type": "Question", "name": "Les infections parodontales peuvent-elles se propager ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'atrophie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la santé parodontale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale." } }, { "@type": "Question", "name": "Une alimentation déséquilibrée influence-t-elle le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie." } } ] } ] }

Sources (10000 au total)

Nomogram predicting the efficacy of transurethral surgery in benign prostatic hyperplasia patients.

This study aimed to develop and validate a nomogram for predicting the efficacy of transurethral surgery in benign prostatic hyperplasia (BPH) patients.... Patients with BPH who underwent transurethral surgery in the West China Hospital and West China Shang Jin Hospital were enrolled. Patients were retrospectively involved as the training group and were ... A total of 426 patients with BPH who underwent transurethral surgery were included in the study, and they were further divided into a training group (n = 245) and a validation group (n = 181). Age (OR... The nomogram we developed included age, the compliance of the bladder, the function of the detrusor, and the severity of bladder outlet obstruction. The discrimination and calibration of the nomogram ...

Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review.

Surgical treatment is important for male lower urinary tract symptom (LUTS) management, but there are few reviews of the risks of reoperation.... To systematically evaluate the current evidence regarding the reoperation rates of surgical treatment for LUTS in accordance with current recommendations and guidelines.... Eligible studies published up to July 2023, were searched for in the PubMed... A total of 119 studies with 130,106 patients were included. The reoperation rate of transurethral resection of the prostate (TURP) at 1, 2, 3, and 5 years was 4.0%, 5.0%, 6.0%, and 7.7%, respectively.... Our results summarized the reoperation rates of 10 surgical procedures over follow-up durations of 1, 2, 3, and 5 years, which could provide reference for urologists and LUTS patients.... https://www.crd.york.ac.uk/PROSPERO, identifier CRD42023445780....

The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia.

Both benign prostatic hyperplasia (BPH) and sarcopenic obesity (SO) are common conditions among older adult/adults males. The prevalent lifestyle associated with SO is a significant risk factor for th... The instrumental variables for SO factors were selected using the inverse variance-weighted method, which served as the primary approach for Mendelian randomization analysis to assess the causal effec... The increase in BMR (OR = 1.248; 95% CI = (1.087, 1.432); P = 0.002) and ALM (OR = 1.126; 95% CI = (1.032, 1.228); P = 0.008) was found to be associated with an elevated risk of BPH. However, no genet... Our findings indicate that a genetic causal association between BMR, ALM and BPH. BMR and ALM are risk factors for BPH. The decrease in BMR and ALM signified the onset and progression of SO, thus SO i...

Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia.

To compare the cost-effectiveness of surgical interventions for BPH.... Using a Markov model, a cost-utility analysis was performed comparing HoLEP, B-TURP, WVTT, and PUL for prostate size <80cc (index patient 1) and HoLEP and SP for prostate size >80cc (index patient 2).... At 5 years, costs per patient for index patient 1 were $3292 (WVTT), $6532 (HoLEP), $6670 (B-TURP), and $10,257 (PUL). HoLEP resulted in the highest QALYs (4.66), followed by B-TURP (4.60), PUL (4.38)... At 5 years follow up, HoLEP is a cost-effective surgical treatment for BPH- independent of gland size....

Nursing Research on Benign Prostatic Hyperplasia Based on Continuous Nursing Care.

To explore the nursing research of prostatic hyperplasia based on continuous nursing and based on the combination of medical care and nursing.... A prospective study of 96 patients with benign prostatic hyperplasia admitted to our hospital from November 2019 to May 2021 was selected. According to the random number table method, they were divide... After 3 months of nursing, the quality of life scores (health status, psychology, social relationship, environment, physiology, and quality of life scores) of the observation group was higher than tho... Continued nursing care based on the combination of medical and health care for prostate hyperplasia is beneficial to improve sleep quality and improve the patient's quality of life score and self-care...

Clinical practice of the transrectal shear-wave elastography in benign prostatic hyperplasia.

To investigate the practical value of the transrectal two-dimensional shear-wave elastography (SWE) in benign prostatic hyperplasia (BPH).... Consecutive male participants with and without BPH constituted the BPH and control group respectively were enrolled prospectively between March and December 2022. Transrectal conventional ultrasound a... There were 200 participants evaluated, including 100 healthy participants and 100 BPH patients. For every one-year increment in age, it was correlated with 0.50 kPa increasement of TZ stiffness. VP an... The prostate is stiffer and larger in BPH group compared to control group. Quantitative stiffness of the TZ was related with age, VP, VTZ and PSA....

A Scientometric Visualization Analysis for Benign Prostatic Hyperplasia from 2016 to 2022.

Benign prostatic hyperplasia (BPH) is a common urological disorder leading to dysuria in middle-aged and elderly men and significantly reduces the quality of life of patients. Technology for BPH has m... The aims of the study were to identify the cooperation of authors, countries, institutions, and explore hot topics' prospects regarding research of BPH. Relevant original articles were obtained from t... A total of 4,738 articles related to study of BPH were identified. We observed a gradual increase in the number of publications from 2016 to 2022. The USA dominated the field in all countries. Shangha...

Assessing the readability and quality of online information about benign prostatic hyperplasia.

Benign prostatic hyperplasia (BPH) affects nearly half of men in their fifties. Patients often search the Internet to better understand their diagnosis, but online health information is not well regul... Three search engines (Google, Bing, and DuckDuckGo) were used with broad search terms including "BPH," "BPH treatment," and "BPH surgery," to mimic a patient diagnosed with BPH seeking further informa... Average reading level of online information about BPH was significantly higher than the recommended level by the American Medical Association (AMA) and United States Department of Health and Human Ser... Although advertisements may hold optimal search result positions and have better readability than nonadvertisements, they have biased and lower quality information. It is important to guide patients t...

[Prostatic hyperplasia: Evaluation of practices in general practice, dissemination, and impact of recommendations].

In 2015, the French Association of Urology, by the male lower urinary tract symptoms Committee, published a practices guideline for the management of prostatic hyperplasia in general practice. Five ye... A specially designed questionnaire was distributed online via the departmental councils of the order and to all regional unions of liberal doctors. The distribution to general practitioners was at the... Two hundred and eighty responses were collected. Fifty-five percent of the population was female. 83 % of the general practitioners did not report having knowledge of the practice guideline. 77 % of d... The practices guideline for the management of prostatic hyperplasia in general practice proposed in 2015 by the male lower urinary tract symptoms Committee seems to be little known by general practiti... 4, grade C....